trending Market Intelligence /marketintelligence/en/news-insights/trending/ao5p3t6uwypig0pz_zl3xq2 content esgSubNav
In This List

Iridex accessory for retina laser systems gets US FDA approval

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Iridex accessory for retina laser systems gets US FDA approval

Iridex Corp. said the U.S. Food and Drug Administration granted 510(k) clearance to its updated TruFocus LIO Premiere laser accessory.

The accessory is a wearable viewing system, for use with the company's retina laser technology.

Mountain View, Calif.-based Iridex develops laser systems to treat sight-threatening eye diseases.